Matthew Kent

Fortune 100 companies trust Matthew to prosecute and defend global price-fixing cartels and other complex disputes. The counsel he provides allows his clients to minimize risk while achieving their business objectives.

Matthew is former co-chair of Alston & Bird’s Antitrust Team, focusing on bet-the-company antitrust litigation and counseling. Matthew and his team have recovered nearly $1 billion in settlements for clients.

Matthew prosecutes and defends global price-fixing cartels for Fortune 100 companies and has extensive experience with the competition issues at the forefront of the pharmaceutical industry.

He advises clients on antitrust issues related to joint ventures and mergers and acquisitions, including filings under the HSR Act and international premerger notification regimes. Matthew assists clients with substantive merger reviews by the U.S. Department of Justice, the Federal Trade Commission, and foreign competition authorities in a host of industries. He also provides ongoing antitrust counseling to clients that enables clients to minimize antitrust risk while achieving their business objectives.